510(k) K974261
K974261 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Dec 11, 1997. The device falls under product code LJK (Antisera, If, Toxoplasma Gondii), a Class II device regulated under 21 CFR 866.3780. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 11, 1997
- Date Received
- Nov 13, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antisera, If, Toxoplasma Gondii
- Device Class
- Class II
- Regulation Number
- 866.3780
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.